Heting LI,Deqiang WANG,Wei CHANG,Hongrui YU,Xiaoming ZOU
申请号：
US16599662
公开号：
US20200071336A1
申请日:
2019.10.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present application relates to a crystalline form of 4-(4-chloroanilino)-7-(2-methylaminocarbonyl-4-oxymethyl)pyridylfuro[2,3-d]pyridazine mesylate (EOC315) that contains crystalline form Mod. I. The present application also relates to a process for the preparation of the crystalline form and the pharmaceutical use of the crystalline form.
